Patent ID: 11970446
Assignee: KANNA HEALTH LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 2:
3. The crystalline form of the besylate salt of mesembrine according to claim 1, wherein the crystalline form is further characterized by peaks in a XRPD pattern at 9.2±0.2, 11.0±0.2, 12.3±0.2, 13.5±0.2, 15.4±0.2, 18.5±0.2, 19.5±0.2, 19.8±0.2, 20.2±0.2, 20.7±0.2, 21.2±0.2, 21.6±0.2, 22.4±0.2, 22.9±0.2, 23.2±0.2, 24.1±0.2, 25.6±0.2, 26.2±0.2, 27.9±0.2, 28.3±0.2, 28.6±0.2, 29.3±0.2, 31.1±0.2, 32.4±0.2, 33.0±0.2, and 33.9±0.2°2θ.